Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai-Uwe Kern

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pain Management|May 11, 2023
Low back pain management in routine clinical practice: what is important for the individual patient?Kai-Uwe Kern
Journal of Pain Research|September 2, 2017
Ambroxol for the treatment of fibromyalgia: science or fiction?Kai-Uwe Kern, Myriam Schwickert
Journal of Pain Research|October 29, 2020
Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic PainFrank Huygen, Kai-Uwe Kern, Concepción Pérez
Pain Practice : the Official Journal of World Institute of Pain|December 3, 2013
Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?Kai-Uwe Kern, Walburga Nowack, Chris Poole
MMW Fortschritte Der Medizin|October 30, 2014
[Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone]Kai-Uwe Kern, Doris Krings, Susanne Waldmann-Rex
MMW Fortschritte Der Medizin|April 22, 2022
[Tapentadol versus classical WHO-III opioids for chronic back pain. Health services research study based on representative data from health insurance funds]Kai-Uwe Kern, Tobias Vogelmann, Thomas R Tölle
Pain Practice : the Official Journal of World Institute of Pain|February 7, 2024
Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in GermanyKai-Uwe Kern, Tamara Quandel, Sina Theis, et al.
Pain Management|January 25, 2020
Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of lifeKai-Uwe Kern, Melanie Sohns, Birgit Heckes, et al.
Pain Practice : the Official Journal of World Institute of Pain|December 20, 2020
Oral or Topical Pain Therapy-How Would Patients Decide? A Discrete Choice Experiment in Patients with Peripheral Neuropathic PainTino Schubert, Kai-Uwe Kern, Sabine Schneider, et al.
Headache|January 18, 2019
Topical Ambroxol 20% for the Treatment of Classical Trigeminal Neuralgia - A New Option? Initial Clinical Case ObservationsKai-Uwe Kern, Myriam Schwickert-Nieswandt, Christian Maihöfner, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pain Management|May 11, 2023
Low back pain management in routine clinical practice: what is important for the individual patient?Kai-Uwe Kern
Journal of Pain Research|September 2, 2017
Ambroxol for the treatment of fibromyalgia: science or fiction?Kai-Uwe Kern, Myriam Schwickert
Journal of Pain Research|October 29, 2020
Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic PainFrank Huygen, Kai-Uwe Kern, Concepción Pérez
Pain Practice : the Official Journal of World Institute of Pain|December 3, 2013
Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?Kai-Uwe Kern, Walburga Nowack, Chris Poole
MMW Fortschritte Der Medizin|October 30, 2014
[Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone]Kai-Uwe Kern, Doris Krings, Susanne Waldmann-Rex
MMW Fortschritte Der Medizin|April 22, 2022
[Tapentadol versus classical WHO-III opioids for chronic back pain. Health services research study based on representative data from health insurance funds]Kai-Uwe Kern, Tobias Vogelmann, Thomas R Tölle
Pain Practice : the Official Journal of World Institute of Pain|February 7, 2024
Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in GermanyKai-Uwe Kern, Tamara Quandel, Sina Theis, et al.
Pain Management|January 25, 2020
Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of lifeKai-Uwe Kern, Melanie Sohns, Birgit Heckes, et al.
Pain Practice : the Official Journal of World Institute of Pain|December 20, 2020
Oral or Topical Pain Therapy-How Would Patients Decide? A Discrete Choice Experiment in Patients with Peripheral Neuropathic PainTino Schubert, Kai-Uwe Kern, Sabine Schneider, et al.
Headache|January 18, 2019
Topical Ambroxol 20% for the Treatment of Classical Trigeminal Neuralgia - A New Option? Initial Clinical Case ObservationsKai-Uwe Kern, Myriam Schwickert-Nieswandt, Christian Maihöfner, et al.
Pageof 2